Published in AIDS Weekly, September 21st, 1998
Dr. Rafael Amado, who heads the Cancer Center team administering the treatment, said eligible patients must be infected with the AIDS virus and have HIV related lymphoma that is responsive to chemotherapy.
Before they receive the high-dose chemotherapy, patients are treated with a standard dose of chemotherapy. They then are given a hormone to stimulate growth of their stem cells, primitive...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.